Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Modular Medical, Inc. stock logo
MODD
Modular Medical
$0.72
-0.6%
$0.76
$0.63
$2.65
$39M0.1783,232 shs39,639 shs
Nephros Inc. stock logo
NEPH
Nephros
$3.42
-3.7%
$3.65
$1.36
$5.00
$37.63M1.1122,918 shs4,665 shs
PAVmed Inc. stock logo
PAVM
PAVmed
$0.53
-8.7%
$0.61
$0.51
$1.90
$9.84M1.08101,615 shs184,527 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$3.41
+1.5%
$3.41
$2.30
$3.93
$34.24M1.4106,902 shs22,926 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Modular Medical, Inc. stock logo
MODD
Modular Medical
-0.56%+0.14%+2.14%-31.25%-54.46%
Nephros Inc. stock logo
NEPH
Nephros
-3.69%-4.23%-14.10%+82.35%+56.12%
PAVmed Inc. stock logo
PAVM
PAVmed
-8.74%-9.69%-11.10%-33.50%-39.26%
PolyPid Ltd. stock logo
PYPD
PolyPid
+1.49%-7.34%-2.29%+22.22%-5.54%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.4806 of 5 stars
0.04.00.00.00.61.70.0
Nephros Inc. stock logo
NEPH
Nephros
1.7144 of 5 stars
3.53.00.00.01.10.80.0
PAVmed Inc. stock logo
PAVM
PAVmed
4.4264 of 5 stars
3.55.00.04.31.80.01.9
PolyPid Ltd. stock logo
PYPD
PolyPid
2.265 of 5 stars
3.65.00.00.00.01.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.00
N/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.0046.24% Upside
PAVmed Inc. stock logo
PAVM
PAVmed
3.00
Buy$19.003,516.29% Upside
PolyPid Ltd. stock logo
PYPD
PolyPid
3.17
Buy$11.80246.04% Upside

Current Analyst Ratings Breakdown

Latest PAVM, NEPH, MODD, and PYPD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$12.00 ➝ $9.00
6/17/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$16.00 ➝ $14.00
6/9/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
6/6/2025
PAVmed Inc. stock logo
PAVM
PAVmed
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.50 ➝ $19.00
6/5/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
6/2/2025
PolyPid Ltd. stock logo
PYPD
PolyPid
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy$11.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/A$0.42 per shareN/A
Nephros Inc. stock logo
NEPH
Nephros
$14.16M2.56$0.02 per share177.40$0.81 per share4.22
PAVmed Inc. stock logo
PAVM
PAVmed
$2.99M3.00N/AN/A($0.92) per share-0.57
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.75 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$18.82M-$0.51N/AN/AN/A-178.13%-151.42%8/12/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.0748.85N/A5.16%9.43%7.20%8/6/2025 (Estimated)
PAVmed Inc. stock logo
PAVM
PAVmed
$39.79M$0.710.74N/AN/A3,711.54%N/A-42.29%8/13/2025 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$29.02M-$4.30N/AN/AN/A-1,069.37%-151.85%8/13/2025 (Estimated)

Latest PAVM, NEPH, MODD, and PYPD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
PAVmed Inc. stock logo
PAVM
PAVmed
-$0.25N/AN/AN/A$0.01 millionN/A
8/13/2025Q2 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.53N/AN/AN/AN/AN/A
6/20/2025Q4 2025
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$0.11-$0.12-$0.01-$0.12N/AN/A
5/15/2025Q1 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million
5/14/2025Q1 2025
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.80-$0.70+$0.10-$0.70N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
PAVmed Inc. stock logo
PAVM
PAVmed
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A
10.69
10.69
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.92
4.64
PAVmed Inc. stock logo
PAVM
PAVmed
N/A
0.37
0.37
PolyPid Ltd. stock logo
PYPD
PolyPid
4.43
0.71
0.71

Institutional Ownership

CompanyInstitutional Ownership
Modular Medical, Inc. stock logo
MODD
Modular Medical
27.47%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
PAVmed Inc. stock logo
PAVM
PAVmed
19.93%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%

Insider Ownership

CompanyInsider Ownership
Modular Medical, Inc. stock logo
MODD
Modular Medical
20.46%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
PAVmed Inc. stock logo
PAVM
PAVmed
7.30%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Modular Medical, Inc. stock logo
MODD
Modular Medical
2054.25 million43.15 millionNot Optionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
PAVmed Inc. stock logo
PAVM
PAVmed
9017.09 million15.85 millionOptionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8010.19 million7.67 millionNo Data

Recent News About These Companies

Craig-Hallum Reaffirms Their Buy Rating on PolyPid (PYPD)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Modular Medical stock logo

Modular Medical NASDAQ:MODD

$0.72 0.00 (-0.56%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.74 +0.02 (+2.80%)
As of 08/1/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Nephros stock logo

Nephros NASDAQ:NEPH

$3.42 -0.13 (-3.69%)
Closing price 08/1/2025 03:50 PM Eastern
Extended Trading
$3.41 -0.01 (-0.26%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

PAVmed stock logo

PAVmed NASDAQ:PAVM

$0.53 -0.05 (-8.74%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.53 +0.01 (+1.07%)
As of 08/1/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$3.41 +0.05 (+1.49%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$3.40 -0.01 (-0.15%)
As of 08/1/2025 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.